[Prostaglandins in myocardial infarct].
D000818:Animals; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology; D002415:Cats; D003326:Coronary Circulation / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy / Q000378:metabolism; D003331:Coronary Vessels / Q000187:drug effects; D004285:Dogs; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy / Q000378:metabolism*; D009206:Myocardium / Q000378:metabolism / Q000473:pathology; D009336:Necrosis; D011453:Prostaglandins / Q000502:physiology*; D011465:Prostaglandins, Synthetic / Q000627:therapeutic use; D013997:Time Factors; D014664:Vasodilation / Q000187:drug effects
D011453:Prostaglandins; D011465:Prostaglandins, Synthetic
Prostaglandiny pri infarkte miokarda.